The novel fusogenic peptides improve the delivery of therapeutics for ovarian cancer through their ability to enhance endosomal escape and delivery of bioactive therapeutics. Epithelial ovarian cancer is the 5th leading cancer among women, with a 49% five-year survival rate. Current treatment strategies for ovarian cancer include surgical removal, chemotherapy, and radiation; however, these treatments often prove ineffective or toxic…
Inventor: Angela Alexander-Bryant, Timothy Samec
Clemson University researchers have developed an in vitro
myocardial therapy screening platform possessing superior
physiological relevance that enables clinically translatable metrics
for therapy efficacy and cardiotoxicity evaluation.
Inventor: William Richardson, Samuel Coeyman, Jonathan G. Heywood
Advanced Materials, Biomedical
Clemson University researchers have developed new delivery and attachment systems for a previously invented collagen-based patch that promotes natural healing of the IVD.
Inventor: Jeremy Mercuri
Clemson University researchers developed a new design that provides an alternative surgical treatment to arthrodesis.
Inventor: John DesJardins,
Clemson University researchers have developed a two-step process for the synthesis of hollow-porous silicon nanostructured materials.
Inventor: Srikanth Pilla, Apparao Rao, Morteza Sabet